Infosys Technologies today said AstraZeneca has awarded it a five-year, multi-million dollar global sourcing deal. AstraZeneca, headquartered in London, is one of the world's leading pharmaceutical companies with sales of $29.55 billion.
Under the agreement, Infosys will deliver end-to-end application maintenance services to AstraZeneca’s global operations in areas such as manufacturing, supply chain, finance, human resources and other corporate functions.
Infosys is delivering the services through a global shared-services model that offers fixed price for outcome-based deliverables, and flexible, unit pricing for managing changes in the base scope of the engagement.
AstraZeneca is transforming its operations through multiple phases, with the first across the United Kingdom and the Nordics, and the subsequent phases focusing on the United States, Europe, Latin America and Asia.
In addition, as part of the transition, AstraZeneca employees in Sweden and the UK will be rebadged to Infosys, thereby strengthening its global delivery network.
